K2 is active at a concentration of 3 μM and above. حسب Estelle Ifrid (10076719)

Immunofluorescence analysis using dual staining for E-cadherin (E-cad) and afadin and F-actin in RPTECs infected with Oki53 and Oki65 at 24 h post-infection. حسب Tetsuya Kakita (4922584)

Proteosomal and pan-caspase inhibitors differentially prevent the disruption of the epithelial cell barrier by the clinical <i>Leptospira</i> isolates. حسب Tetsuya Kakita (4922584)

Ca²⁺ supplementation <i>in vitro</i> has no impact on expression of CD69 on human primary Vγ2⁺ T cells, MAIT cells, and B cells, and on the production of the... حسب Yusuf Cem Eskiocak (10789281)

Changes in TEER and permeability of EA.hy926 cells exposed to EVs or pellets from infected or uninfected macrophages. حسب Myriam Lucia Velandia-Romero (8259726)

"…At time 0, the DB concentration was 27 μg/ml, then at 3 h it increased to 80 μg/ml and at 6 h p.e some conditions decreased the permeability up to 60 μg/ml; in particular endothelial cells exposed to <i>P(+)</i> had a significant decrease of DB concentration (25 μg/ml) at this time. …"

Port-sourced PM_2.5 (μg/m³) concentrations 2017 at the Barcelona neighbourhood level. حسب Natalie Mueller (3406370)

الموضوعات:

Growth the <i>cop</i>^- strain in liquid chemically defined media with and without 8 μM Cu(II). حسب Javiera Norambuena (137228)

Amplitudes (in μV) of the N2 and CRN in compatible and incompatible trials after neutral and negative pictures in the FC and FI condition before and after training at electrode Fz,... حسب Rosa Grützmann (14160149)

Mean <i>μ</i>_<i>i</i> and standard deviation <i>σ</i>_<i>i</i> of <i>i</i> = [0%, 1%, 2.5%, 5%] concentration datasets. حسب Ishriak Ahmed (14265562)

Impact of 8-MOP concentration (0 ng/ml, 200 ng/ml, or 300 ng/ml) on cellular response after a 2 J/cm² UVA dose. حسب Marie Laulhé (6416483)

Detection of oxidized proteins by oxyblot in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG. حسب Patrick Mordel (17020879)

Intact FGF23-to-C-terminal FGF23 mean (standard error) ratios, stratified by concomitant baseline IV VDRA. حسب Takashi Shigematsu (829751)

الموضوعات:

Fig 3 - حسب Takashi Shigematsu (829751)

الموضوعات:

Baseline characteristics of study patients. حسب Takashi Shigematsu (829751)

الموضوعات:

Fig 1 - حسب Takashi Shigematsu (829751)

الموضوعات:

Numbers, percentages, and between-group differences of patients who achieved the target parameters during Weeks 28 to 30 stratified by concomitant baseline IV VDRA dose. حسب Takashi Shigematsu (829751)

الموضوعات:

Correlations between intact FGF23 and C-terminal FGF23 at Week 0 and Week 30. حسب Takashi Shigematsu (829751)

الموضوعات:

Fig 2 - حسب Takashi Shigematsu (829751)

الموضوعات:

Incidences of ADRs stratified by concomitant baseline IV VDRA dose. حسب Takashi Shigematsu (829751)

الموضوعات:

Reduction of OTUB1 decreased NS2-mediated vRNP nuclear export. حسب Yu-Jyun Li (18700176)